| Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil Z Lei, IB Tan, K Das, N Deng, H Zouridis, S Pattison, C Chua, Z Feng, ... Gastroenterology 145 (3), 554-565, 2013 | 460 | 2013 |
| The Effects of Obesity on Anti-Cancer Immunity and Cancer Immunotherapy MJ Woodall, S Neumann, K Campbell, ST Pattison, SL Young Cancers 12 (5), 1230, 2020 | 88 | 2020 |
| Triple negative breast cancer in a male‐to‐female transsexual ST Pattison, BR McLaren Internal medicine journal 43 (2), 203-205, 2013 | 51 | 2013 |
| Gene expression profiling of metastatic and nonmetastatic colorectal cancer cell lines M Futschik, A Jeffs, S Pattison, N Kasabov, M Sullivan, A Merrie, A Reeve Genome letters 1 (1), 26-34, 2002 | 43 | 2002 |
| Immunological battlefield in gastric cancer and role of immunotherapies M Wang, RA Busuttil, S Pattison, PJ Neeson, A Boussioutas World Journal of Gastroenterology 22 (28), 6373, 2016 | 36 | 2016 |
| Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer. S Pattison, C Mitchell, S Lade, T Leong, RA Busuttil, A Boussioutas PloS one 12 (9), e0183891, 2017 | 29 | 2017 |
| The epigenetic landscape of circulating tumour cells SS Vasantharajan, MR Eccles, EJ Rodger, S Pattison, JL McCall, ES Gray, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (2), 188514, 2021 | 27 | 2021 |
| Proton pump inhibitor use: systematic review of global trends and practices LGT Shanika, A Reynolds, S Pattison, R Braund European Journal of Clinical Pharmacology 79 (9), 1159-1172, 2023 | 22 | 2023 |
| SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence RA Busuttil, J George, CM House, S Lade, C Mitchell, NS Di Costanzo, ... Gastric Cancer 24, 589-601, 2021 | 18 | 2021 |
| A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer K Wang, E Li, RA Busuttil, JC Kong, S Pattison, JJY Sung, J Yu, ... Therapeutic Advances in Medical Oncology 12, 1758835920930359, 2020 | 14 | 2020 |
| Predictors of outcome after surgery for gastric cancer in a Western cohort S Pattison, GB Mann, G Crosthwaite, S Lade, C Mitchell, T Leong, ... ANZ journal of surgery 86 (6), 469-474, 2016 | 12 | 2016 |
| Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international … J Santucci, M Tacey, B Thomson, M Michael, R Wong, J Shapiro, ... European Journal of Cancer 174, 102-112, 2022 | 10 | 2022 |
| An epigenetic signature of advanced colorectal cancer metastasis EJ Rodger, G Gimenez, P Ajithkumar, PA Stockwell, S Almomani, ... IScience 26 (6), 2023 | 8 | 2023 |
| Consensus-derived quality performance indicators for neuroendocrine tumour care B Woodhouse, S Pattison, E Segelov, S Singh, K Parker, G Kong, ... Journal of clinical medicine 8 (9), 1455, 2019 | 8 | 2019 |
| Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours MS Elston, A Love, D Kevat, R Carroll, ZR Siow, S Pattison, V Boyle, ... Cancer medicine 10 (23), 8405-8411, 2021 | 7 | 2021 |
| Assessment of a Size-Based Method for Enriching Circulating Tumour Cells in Colorectal Cancer SS Vasantharajan, E Barnett, ES Gray, JL McCall, EJ Rodger, MR Eccles, ... Cancers 14 (14), 3446, 2022 | 6 | 2022 |
| The influence of microbial metabolites in the gastrointestinal microenvironment on anticancer immunity S Neumann, EM Peyroux, MJ Woodall, NJ Shields, SL Young, ST Pattison Current Cancer Treatment, 2019 | 5 | 2019 |
| Pathophysiology of hereditary diffuse gastric cancer S Pattison, A Boussioutas Gastric Cancer: Principles and Practice, 91-109, 2015 | 3 | 2015 |
| Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis P Ajithkumar, SS Vasantharajan, S Pattison, JL McCall, EJ Rodger, ... International Journal of Molecular Sciences 25 (2), 874, 2024 | 2 | 2024 |
| The Quality of Online Information for an Uncommon Malignancy—Neuroendocrine Tumours (NETs) S Sohail, V Zuk, T Halfdanarson, D Chan, S Pattison, R Vasdev, C Law, ... Current Oncology 28 (1), 842-846, 2021 | 2 | 2021 |
